ym 529 has been researched along with osteoprotegerin in 3 studies
| Studies (ym 529) | Trials (ym 529) | Recent Studies (post-2010) (ym 529) | Studies (osteoprotegerin) | Trials (osteoprotegerin) | Recent Studies (post-2010) (osteoprotegerin) |
|---|---|---|---|---|---|
| 140 | 23 | 71 | 5,108 | 212 | 2,726 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cui, N; Guo, C; Hashimoto, S; Noma, H; Nomura, T; Okamoto, M; Sato, M; Shibahala, T; Takagi, R; Yokoo, K; Yu, G | 1 |
| Fukata, S; Hagino, H; Kishimoto, Y; Mizumura, H; Tanishima, S; Teshima, R | 1 |
| Masuda, H; Tanaka, S | 1 |
1 review(s) available for ym 529 and osteoprotegerin
| Article | Year |
|---|---|
[Drugs under development for osteoporosis ].
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bone Density Conservation Agents; Cathepsin K; Cathepsins; Denosumab; Diphosphonates; Drug Design; Humans; Ibandronic Acid; Imidazoles; Organometallic Compounds; Osteoporosis; Osteoprotegerin; RANK Ligand; Selective Estrogen Receptor Modulators; Teriparatide; Thiophenes | 2009 |
2 other study(ies) available for ym 529 and osteoprotegerin
| Article | Year |
|---|---|
Effect of YM529 on a model of mandibular invasion by oral squamous cell carcinoma in mice.
Topics: Animals; Body Weight; Bone Resorption; Carcinoma, Squamous Cell; Carrier Proteins; Cell Line, Tumor; Diphosphonates; Disease Models, Animal; Gene Expression; Glycoproteins; Imaging, Three-Dimensional; Imidazoles; Interleukin-6; Male; Mandible; Membrane Glycoproteins; Mice; Mice, Inbred C3H; Mouth Neoplasms; Neoplasm Invasiveness; Osteoclasts; Osteoprotegerin; Parathyroid Hormone-Related Protein; RANK Ligand; Receptor Activator of Nuclear Factor-kappa B; Receptors, Cytoplasmic and Nuclear; Receptors, Tumor Necrosis Factor; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tomography, X-Ray Computed; Tumor Necrosis Factor-alpha | 2005 |
Minodronic acid influences receptor activator of nuclear factor kappaB ligand expression and suppresses bone resorption by osteoclasts in rats with collagen-induced arthritis.
Topics: Animals; Arthritis, Experimental; Bone Density Conservation Agents; Bone Resorption; Diphosphonates; Disease Models, Animal; Female; Imidazoles; Osteoprotegerin; RANK Ligand; Rats; Rats, Sprague-Dawley | 2007 |